Belzutifan Improves Progression-Free Survival for Renal Cell Carcinoma Over Everolimus
source: shutterstock.com

Belzutifan Improves Progression-Free Survival for Renal Cell Carcinoma Over Everolimus

The Phase 3 LITESPARK-005 trial sought to understand whether Welireg (belzutifan) was effective in treating advanced renal cell carcinoma (RCC) when compared to other treatments, such as everolimus. According to…

Continue Reading Belzutifan Improves Progression-Free Survival for Renal Cell Carcinoma Over Everolimus
September 17-23 is Balance Awareness Week: Spreading Vestibular Disorders Awareness
source: pixabay.com

September 17-23 is Balance Awareness Week: Spreading Vestibular Disorders Awareness

This year, September 17-23 is being recognized as Balance Awareness Week. Organized by the Vestibular Disorders Association, a Patient Worthy partner organization, the goal of this campaign is to help…

Continue Reading September 17-23 is Balance Awareness Week: Spreading Vestibular Disorders Awareness